What is he best known for?
The fields of study he is best known for:
Hongbo Zhang mainly investigates Drug delivery, Nanotechnology, Nanoparticle, Biocompatibility and Porous silicon.
His study in Drug delivery is interdisciplinary in nature, drawing from both Biophysics, Membrane, Oligonucleotide and Characterization.
His Nanotechnology research includes elements of Aptamer and DNA.
The Nanoparticle study which covers Nanocomposite that intersects with Core, Colloidal gold and Nanocrystal.
His research in Biocompatibility focuses on subjects like Combination chemotherapy, which are connected to Click chemistry.
His Porous silicon research incorporates elements of Cancer cell and Dextran.
His most cited work include:
- Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems. (180 citations)
- Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. (135 citations)
- The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility (122 citations)
What are the main themes of his work throughout his whole career to date?
Hongbo Zhang spends much of his time researching Nanotechnology, Drug delivery, Nanoparticle, Cancer cell and Porous silicon.
Hongbo Zhang interconnects Dextran and Combination therapy in the investigation of issues within Nanotechnology.
His Drug delivery study incorporates themes from Nanocomposite, Liposome, DNA and Controlled release.
His Nanoparticle research focuses on Biocompatibility and how it connects with Biomedical engineering.
His research in Cancer cell intersects with topics in Cancer research, Biophysics, Cancer immunotherapy, Doxorubicin and Membrane.
As part of the same scientific family, Hongbo Zhang usually focuses on Photothermal therapy, concentrating on Drug and intersecting with Phospholipid and Cytotoxicity.
He most often published in these fields:
- Nanotechnology (75.59%)
- Drug delivery (54.93%)
- Nanoparticle (56.34%)
What were the highlights of his more recent work (between 2019-2021)?
- Cell biology (18.78%)
- Cancer research (18.78%)
- Regeneration (17.37%)
In recent papers he was focusing on the following fields of study:
Hongbo Zhang mostly deals with Cell biology, Cancer research, Regeneration, Nanoparticle and Cancer cell.
The study incorporates disciplines such as Inflammation, Self-healing hydrogels, Genetic enhancement and Transfection in addition to Cell biology.
In his study, Microfluidics, Doxorubicin and Paclitaxel is inextricably linked to Mesoporous silica, which falls within the broad field of Nanoparticle.
Hongbo Zhang studied Cancer cell and Drug delivery that intersect with Zeolitic imidazolate framework.
In his research, Photothermal therapy is intimately related to Biophysics, which falls under the overarching field of Peptide.
Hongbo Zhang merges many fields, such as Fabrication and Nanotechnology, in his writings.
Between 2019 and 2021, his most popular works were:
- Borderless collaboration is needed for COVID-19-A disease that knows no borders. (45 citations)
- Borderless collaboration is needed for COVID-19-A disease that knows no borders. (45 citations)
- Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications (25 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Nanoparticle, Controlled release, Biophysics, Gelatin and Cancer research.
His research on Nanoparticle concerns the broader Nanotechnology.
His Controlled release research is multidisciplinary, relying on both Surface modification, Moiety, Combinatorial chemistry, Dichloroacetic acid and Drug carrier.
His work focuses on many connections between Gelatin and other disciplines, such as Skin flap, that overlap with his field of interest in Biomedical engineering and Biocompatibility.
His Cancer research research includes elements of Cancer cell, Cancer, Targeted therapy, Oncogene and Genetic enhancement.
His studies examine the connections between Cancer cell and genetics, as well as such issues in Decellularization, with regards to Drug delivery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
